In 134 lung squamous cell carcinoma tissue samples, there were 7 (5.2%) EGFR mutations, 6 (4.5%) KRAS mutations, 12 (9.0%) PIK3CA mutations, 1 (0.7%) BRAF mutations and 1 (0.7%) MET amplifications. Here, MET is linked to squamous cell lung carcinoma.